.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Cristina Tassorelli

Vorsitz

07.12.2022
12:45 – 14:15
Scientific session
Covid-19 and vaccines related headaches and cluster headache
Strauss 2-3

Invited speaker

07.12.2022
10:15 – 10:45 23 Min. 7 Min.
Invited lecture
ICHD 2022 - Is it time for operationalization?

Vortrag

07.12.2022
10:45 – 10:46 1 Min. 0 Min.
On Demand
New insights into headache classification

Weitere Beteiligungen

07.12.2022
14:05 – 14:15 8 Min. 2 Min.
Abstract lecture
A6
Role of the Default Mode Network in Episodic Cluster Headache: Cerebral Connectivity Analysis with Hd-Eeg
Cluster headache , Data science in research and digital medicine
08.12.2022
16:00 – 16:05 3 Min. 2 Min.
ePoster
P60
Brain connectivity modifications induced by monoclonal antibodies targeting the CGRP pathway in migraine patients: a prospective HD-EEG, open-label, study
CGRP inhibitors in the clinic, Neuroimigang in headache disorders
08.12.2022
16:05 – 16:10 3 Min. 2 Min.
ePoster
P94
Vestibular signs in experimentally induced migraine attacks: a post-hoc, exploratory analysis
Headache, thalamus and other brain nuclei, Migraine
08.12.2022
16:40 – 16:45 3 Min. 2 Min.
ePoster
P79
Impact of SARS-CoV2 vaccine on migraine course in patients receiving CGRP monoclonal antibodies
CGRP inhibitors in the clinic, COVID and headache
08.12.2022
16:45 – 16:50 3 Min. 2 Min.
ePoster
P80
The Regional Outreach Programme of the International Headache Society in sub-Saharian Africa: partnership with the DREAM program and results from the first survey on headache training
Data science in research and digital medicine, Multidisciplinary clinical assessments
09.12.2022
15:35 – 15:40 3 Min. 2 Min.
ePoster
P121
The virtual "Enfacement Illusion" on pain perception in patients suffering from chronic migraine: Preliminary data from a randomized controlled trial
Migraine, Multidisciplinary clinical assessments
09.12.2022
15:40 – 15:45 3 Min. 2 Min.
ePoster
P174
HEADWORK as innovative tool for monitoring MABs efficacy in migraine and their influence on work activity.
CGRP inhibitors in the clinic, Migraine
09.12.2022
15:45 – 15:50 3 Min. 2 Min.
ePoster
P193
Searching for the predictors of response to BoNT-A in migraine using a machine learning approach
Data science in research and digital medicine, Multidisciplinary clinical assessments
09.12.2022
16:00 – 16:05 3 Min. 2 Min.
ePoster
P108
A retrospective real-life multicenter study on concurrent oral preventives in patients with chronic migraine treated with botulinum toxin
Epidemiology, Migraine
09.12.2022
16:15 – 16:20 3 Min. 2 Min.
ePoster
P266
Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
CGRP inhibitors in the clinic, Migraine
09.12.2022
16:25 – 16:30 3 Min. 2 Min.
ePoster
P113
Psychopathological disorders in chronic migraine: is there an association with the endocannabinoid system?
Migraine, Multidisciplinary clinical assessments
09.12.2022
16:35 – 16:40 3 Min. 2 Min.
ePoster
P270
Past Preventive Migraine Treatment in Patients Initiating Fremanezumab in Clinical Practice: Interim Data from the PEARL Study
CGRP inhibitors in the clinic, Migraine
09.12.2022
16:40 – 16:45 3 Min. 2 Min.
ePoster
P117
Treatment Responder Rates of Oral Atogepant for the Preventive Treatment of Chronic Migraine: Results From the PROGRESS Trial
Migraine
09.12.2022
17:15 – 17:25 8 Min. 2 Min.
Abstract lecture (online)
A28
Inhibition of peripheral FAAH alleviates hyperalgesia induced by acute dural inflammation in experimental migraine
Basic science, animal models in headache research, Migraine